West Pharmaceutical Services, Inc. (WST) Tops Q4 EPS by 4c, Offers FY12 EPS Outlook
Tweet Send to a FriendGet Alerts WST Hot Sheet
Price: $68.42 +1.08%
EPS Growth %: +7.4%
Financial Fact:
Net sales: 339.4M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +7.4%
Financial Fact:
Net sales: 339.4M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade WST Now!
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.59, $0.04 better than the analyst estimate of $0.55. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $290.05 million.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.37-$2.55, versus the consensus of $2.51.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.37-$2.55, versus the consensus of $2.51.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
- Brady Corp. (BRC) Misses Q3 EPS by 5c; Guides Q4 EPS Below Views
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
